BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33270330)

  • 1. Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability.
    Xu Y; Xu G; Dang H; Qu W; Chang D; He X; Li M; Wang Q
    Environ Toxicol; 2021 Apr; 36(4):686-693. PubMed ID: 33270330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational modification of OCT4 in breast cancer tumorigenesis.
    Cho Y; Kang HG; Kim SJ; Lee S; Jee S; Ahn SG; Kang MJ; Song JS; Chung JY; Yi EC; Chun KH
    Cell Death Differ; 2018 Nov; 25(10):1781-1795. PubMed ID: 29511337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISG15 enhances glioma cell stemness by promoting Oct4 protein stability.
    Dai Y; Yu T; Yu C; Lu T; Zhou L; Cheng C; Ni H
    Environ Toxicol; 2022 Sep; 37(9):2133-2142. PubMed ID: 35506701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
    Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
    Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.
    Chang YC; Yang YF; Chiou J; Tsai HF; Fang CY; Yang CJ; Chen CL; Hsiao M
    Cell Death Dis; 2020 Mar; 11(3):195. PubMed ID: 32188842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
    Cho JM; Lee HJ; Chung JH; Kim WY; Kang MH; Ha KS; Woo SU; Lee JB
    Anticancer Res; 2020 Jul; 40(7):3801-3809. PubMed ID: 32620619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity.
    Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X
    Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2.
    Huang Z; Shen G; Gao J
    Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
    Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
    Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation.
    Maiuthed A; Bhummaphan N; Luanpitpong S; Mutirangura A; Aporntewan C; Meeprasert A; Rungrotmongkol T; Rojanasakul Y; Chanvorachote P
    J Biol Chem; 2018 Aug; 293(35):13534-13552. PubMed ID: 29986880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itch, an E3 ligase of Oct4, is required for embryonic stem cell self-renewal and pluripotency induction.
    Liao B; Zhong X; Xu H; Xiao F; Fang Z; Gu J; Chen Y; Zhao Y; Jin Y
    J Cell Physiol; 2013 Jul; 228(7):1443-51. PubMed ID: 23255053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT4 directly regulates stemness and extracellular matrix-related genes in human germ cell tumours.
    Song B; Kim DK; Shin J; Bae SH; Kim HY; Won B; Kim JK; Youn HD; Kim ST; Kang SW; Jang H
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1980-1986. PubMed ID: 30078675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
    PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner.
    Liao B; Jin Y
    Cell Res; 2010 Mar; 20(3):332-44. PubMed ID: 19997087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
    Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
    Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
    Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
    Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.